Viewing Study NCT06310304

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2026-03-13 @ 12:24 PM
Study NCT ID: NCT06310304
Status: COMPLETED
Last Update Posted: 2024-06-05
First Post: 2024-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.
Sponsor: Incyte Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Participants View
Keywords:

Keywords

Keyword Brief Keyword Text View
None INCB018424 View
None Ruxolitinib View
None Healthy Participants View